A539 및 NCI-H460 인체 폐암세포의 증식 및 apoptosis 유도에 미치는 가미삼기보폐탕의 영향 = Effect of Gamisamgibopae-tang on the Growth and Apoptosis of A539 and NCI-H460 Human Lung Cancer Cells

다국어 초록 (Multilingual Abstract)

Objective : This study was designed to investigate the effect of the water extract of Gamisamgibopae-tang(GMSGBPT), an oriental herbal formulation, on the growth of NCI-H460 and A549 human non-small-cell lung cancer cell lines. Methods : Cytotoxicity and cell morphology were evaluated by MTT assay and inverted microscope, respectively. Apoptosis was detected using agarose gel electrophoresis and flow cytometer. The expression levels of mRNAs and proteins of target genes were determined by RT-PCR and western blot analyses, respectively Result and Conclusion : We found that exposure of A549 cells to GMSGBPT resulted in the growth inhibition in a dose-dependent manner as measured by MTT assay, but GMSGBPTdid not affect the growth of NCI-H460 cells. The anti-proliferative effect of GMSGBPT treatment in A549 cells was associated with morphological changes, formation of apoptotic bodies and DNA fragmentation, and flow cytometry analysis confirmed that GMSGBPT treatment increased the populations of apoptotic-sub G1 phase. Growth inhibition and apoptotic cell death by GMSGBPT were connected with a up-regulation of cyclin-dependent kinase inhibitor p21 (WAF1/CIP1) mRNA and protein in a tumor suppressor p53-independent fashion. However GMSGBPT treatment did not affect other growth regulation-related genes such as early growth response-1 (Egr-1), nonsteroidal anti-inflammatory drug (NSAID)-activated gene-1 (NAG-1), inducible nitric oxide synthase (iNOS), cyclooxygenases (COXs), telomere-regulatory factors in A549 orNCI-H460 cells. Taken together, these findings partially provide novel insights into the possible molecular mechanism of the anti-cancer activity of GMSGBPT.

참고문헌 (Reference)

1 대한결핵 및 호흡기학회, "호흡기학" 군자출판사 602-605, 2004

2 허만규, "인체폐암세포 NCI-H460 및 A549의 apoptosis 유발에 미치는 參_補肺湯의 영향" 대한한방내과학회 28 (28): 473-491, 2007

3 한의과대학본초학편찬위원회, "본초학" 영림사 499-500, 2006

4 윤창렬, "대전" 난경연구집성 768-, 2002

5 서울대학교 의과대학 내과학교실, "내과학" 고려의학 32-, 2005

6 강락원, "길경 수용액 추출물에 의한 인체 폐암세포의 성장억제 기전 연구" 대한동의병리학회 17 (17): 182-188, 2003

7 "경리. 중국고대의방진본비본전집 33권. 전국도서관문헌축미복제중심; 2004; p. 359"

8 陳無擇, "陳無擇三因方" 大中國圖書公司 10-, 0000

9 李梴, "醫學入門" 남산당 212-213, 1980

10 이성열, "桔梗이 人體 肺癌細胞에 미치는 영향에 대한 실험적 연구" 대한동의병리학회 17 (17): 1019-1030, 2003

11 李東垣, "東垣醫集" 인민위생출판사 419-, 1993

12 Sato, T., "p53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G(2) cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin" 70 : 528-534, 2002

13 Levesque, A.A., "p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?" 28 : 13-20, 2007

14 de Belle, I., "p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53- dependent apoptosis" 18 : 3633-3642, 1999

15 Yang, H.L., "p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells" 88 : 763-772, 2003

16 Li, P.X., "downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression" 275 : 20127-20135, 2000

17 el-Deiry, W.S., "Vogelstein, WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis" 54 : 1169-1174, 1994

18 Massarelli, E., "Use of novel second-line targeted therapies in non-small cell lung cancer" 33 : 9-16, 2006

19 Wu, R., "Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas" 13 : 143-150, 2007

20 Yamamoto, Y., "Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer" 107 : 135-142, 2001

21 Worden, F.P., "Therapeutic advances in small cell lung cancer" 9 : 565-579, 2000

22 Kelly, K., "The role of targeted agents in adjuvant therapy for non-small cell lung cancer" 11 : 5027-5029, 2005

23 Harris, S.L., "The p53 pathway: positive and negative feedback loops" 24 : 2899-2908, 2005

24 Robles, A.I., "The p53 network in lung carcinogenesis" 21 : 6898-6907, 2002

25 Ding, Z., "The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways" 7 : 3336-3342, 2001

26 Calogero, A., "The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas" 7 : 2788-2798, 2001

27 Sherr, C.J., "The Pezcoller lecture: cancer cell cycles revisited" 60 : 3689-3695, 2000

28 Virolle, T., "The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling" 3 : 1124-1128, 2001

29 Cerni, C., "Telomeres, telomerase, and myc" 462 : 31-47, 2000

30 Chen, K.H., "Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells" 73 : 215-227, 2007

31 Liu, C., "Suppression of growth and transformation and induction of apoptosis by EGR-1" 5 : 3-28, 1998

32 Ke, J., "Role of NF-kappaB in TNF-alpha-induced COX-2 expression in synovial fibroblasts from human TMJ" 86 : 363-367, 2007

33 Chen, C., "Review of the Cox model" 61 : 521-523, 2000

34 Baek, S.J., "Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53" 23 : 425-434, 2002

35 Bunz, F., "Requirement for p53 and p21 to sustain G2 arrest after DNA damage" 282 : 1497-1501, 1998

36 Xu, Y., "Regulation of p53 responses by post- translational modifications" 10 : 400-403, 2003

37 Weinrich, S.L., "Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT" 17 : 498-502, 1997

38 Rosch, S., "Prostaglandin E2 induces cyclooxygenase-2 expression in human nonpigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases" 338 : 1171-1178, 2005

39 Suzuki, A., "Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A" 7 : 721-728, 2000

40 Bode, A.M., "Post-translational modification of p53 in tumorigenesis" 4 : 793-805, 2004

41 Tan, M., "PTGF-ß, a type beta transforming growth factor (TGF-ß) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-ß signaling pathway" 97 : 109-114, 2000

42 Surh, Y.J., "Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation" 480 : 243-268, 2001

43 Steinke, K., "Lung tumors" 107-122, 2006

44 Balzary, R.W., "Lipopolysaccharide induces epithelium- and prostaglandin E(2)- dependent relaxation of mouse isolated trachea through activation of cyclooxygenase (COX)-1 and COX-2" 317 : 806-812, 2006

45 Chen, P., "Involvement of PKC, p38 MAPK and AP-2 in IL-1beta- induced expression of cyclooxygenase-2 in human pulmonary epithelial cells" 11 : 18-23, 2006

46 Nieminen, R., "Inhibitors of mitogen- activated protein kinases downregulate COX-2 expression in human chondrocytes" 5 : 249-255, 2005

47 Brugarolas, J., "Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation" 96 : 1002-1007, 1999

48 Soloff, M.S., "In situ analysis of interleukin-1-induced transcription of cox-2 and il-8 in cultured human myometrial cells" 145 : 1248-1254, 2004

49 Gajra, A., "Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease" 42 : 51-57, 2003

50 Scarpati, M.D., "Gemcitabine and small cell lung cancer" 34 : 313-314, 2001

51 Yang, C.H., "Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer" 86 : 190-195, 2002

52 Baek, S.J., "Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1" 279 : 6883-6892, 2004

53 Huang, R.P., "Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain" 55 : 5054-5062, 1995

54 Chang, B.D., "Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases" 97 : 4291-4296, 2000

55 Huang, R.P., "Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation" 72 : 102-109, 1997

56 Narayan, S., "DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2" 85 : 898-901, 2001

57 Dempke, W., "Cyclooxygenase-2: a novel target for cancer chemotherapy?" 127 : 411-417, 2001

58 Koki, A., "Cyclooxygenase-2 in human pathological disease" 507 : 177-184, 2002

59 Sawaoka, H., "Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo" 79 : 1469-1477, 1999

60 Baek, S.J., "Cyclooxygenase inhibitors regulate the expression of a TGF-ß superfamily member that has proapoptotic and antitumorigenic activities" 59 : 901-908, 2001

61 Brown, J.R., "Cyclooxygenase as a target in lung cancer" 10 : 4266-4299, 2004

62 Qiao, L., "Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53" 36 : 39-48, 2002

63 Cho, J.W., "Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets" 37 : 186-192, 2005

64 Kyo, S., "Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy" 21 : 688-697, 2002

65 Hengst, L., "Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1)" 12 : 3882-3888, 1998

66 Raez, L.E., "Chemotherapy for advanced non-small-cell lung cancer" 2 : 173-178, 2004

67 FitzGerald, G.A., "COX-2 and beyond: Approaches to prostaglandin inhibition in human disease" 2 : 879-890, 2003

68 Fabian, D., "Apoptotic processes during mammalian preimplantation development" 64 : 221-231, 2005

69 Fabian, D., "Apoptotic processes during mammalian preimplantation development" 64 : 221-231, 2005

70 Poole, J.C., "Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)" 269 : 1-12, 2001

71 Vaziri, H., "ATM- dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase" 16 : 6018-6033, 1997

72 Shay, J.W., "A survey of telomerase activity in human cancer" 33 : 787-791, 1997

73 Kiernan, P.D., "A pragmatic and successful approach to treating nonsmall-cell lung carcinoma" 80 : 840-857, 2004